Enigmatic variation
Variability in presentation and prognosis of transient myeloproliferative disorder (TMD) in infants with Down syndrome (DS) has perplexed clinicians and scientists for decades and is explored in this issue of Blood by Gamis and colleagues from the Children's Oncology Group (COG).
| 主要な著者: | , |
|---|---|
| フォーマット: | Journal article |
| 言語: | English |
| 出版事項: |
American Society of Hematology
2011
|